Background: The plethysmographic shift volume-flow loop (sR-loop) measured during tidal breathing allows the determination of several lung function parameters such as the effective specific airway resistance (sR), calculated from the ratio of the integral of the resistive aerodynamic specific work of breathing (sWOB) and the integral of the corresponding flow-volume loop. However, computing the inspiratory and expiratory areas of the sR-loop separately permits the determination of further parameters of airway dynamics. Therefore, we aimed to define the discriminating diagnostic power of the inspiratory and expiratory sWOB (sWOB, sWOB), as well as of the inspiratory and expiratory sR (sR and sR ), for discriminating different functional phenotypes of chronic obstructive lung diseases.
Methods: Reference equations were obtained from measurement of different databases, incorporating 194 healthy subjects (35 children and 159 adults), and applied to a collective of 294 patients with chronic lung diseases (16 children with asthma, aged 6-16 years, and 278 adults, aged 17-92 years). For all measurements, the same type of plethysmograph was used (Jaeger Würzburg, Germany).
Results: By multilinear modelling, reference equations of sWOB, sWOB, sR and sR were derived. Apart from anthropometric indices, additional parameters such as tidal volume (V), the respiratory drive (P), measured by means of a mouth occlusion pressure measurement 100 ms after inspiration and the mean inspiratory flow (V/T) were found to be informative. The statistical approach to define reference equations for parameters of airway dynamics reveals the interrelationship between covariants of the actual breathing pattern and the control of breathing.
Conclusions: We discovered that sWOB, sWOB, sR and sR are new discriminating target parameters, that differentiate much better between chronic obstructive diseases and their subtypes, especially between chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO), thus strengthening the concept of precision medicine.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148667 | PMC |
http://dx.doi.org/10.1136/bmjresp-2023-002142 | DOI Listing |
BMC Pulm Med
January 2025
The First Affiliated Hospital of Sun Yat-Sen University, Guangdong, 510080, China.
Aim: The aim of this systematic review and meta-analysis was to explore the effects of different pulmonary rehabilitation on respiratory function in mechanically ventilated patients and to determine the optimal type of intervention.
Method: A comprehensive search was conducted using PubMed, Embase, Web of Science, Joanna Briggs Institute(JBI), and the Cochrane Library from their inception until September 16th, 2024. The search targeted randomized controlled trials (RCTs) comparing pulmonary rehabilitation or usual care, for improving respiratory function in mechanically ventilated patients.
Sr Care Pharm
January 2025
2 Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas.
The first combination inhaled corticosteroid and short-acting beta₂ agonist (ICS-SABA) was approved by the Food and Drug Administration (FDA) in 2023 for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma exacerbations in patients 18 years of age and older. The recently approved product contains an ICS-albuterol combination. The 2024 Global Initiative for Asthma (GINA) guidelines recommend as-needed ICS-formoterol as the preferred asthma reliever therapy; however, a GINA alternative recommendation is the use of ICS whenever an as-needed (SABA) is used.
View Article and Find Full Text PDFFront Physiol
December 2024
Department of Health Sciences, Public University of Navarre (UPNA), Pamplona, Spain.
In this quasi-experimental before-after trial, we investigated the effects of a high-intensity, low-repetition inspiratory muscle training (HI-LRMT) protocol on respiratory muscle strength in instrumental musicians. In addition, was to estimate the prevalence of "non-responders" (NRs) in terms of muscle force after intervention. Healthy musicians ( = 48) were divided into 2 groups: HI-LRMT ( = 33) and a control group that did not train (CG, = 15).
View Article and Find Full Text PDFDevice
December 2024
Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716.
Modeling aerosol dynamics in the airways is challenging, and most modern personalized tools consider only a single inhalation maneuver through less than 10% of the total lung volume. Here, we present an modeling pipeline to produce a device that preserves patient-specific upper airways while approximating deeper airways, capable of achieving total lung volumes over 7 liters. The modular system, called TIDAL, includes tunable inhalation and exhalation breathing capabilities with resting flow rates up to 30 liters per minute.
View Article and Find Full Text PDFLymphat Res Biol
December 2024
Division of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Istanbul Okan University, Istanbul, Turkey.
Lymphedema is a chronic, progressive condition that has major physical and psychological consequences. It was aimed to examine the respiratory functions, respiratory muscle strength, physical activity level, and functionality of patients with lower extremity lymphedema and to compare them with healthy controls. A total of 82 individuals (29.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!